PHASE-I PHASE-II TRIAL OF INTRAVESICAL METHOTREXATE FOR SUPERFICIAL BLADDER-TUMORS

被引：0

作者：

STERNBERG, CN

YAGODA, A

BANDER, NH

WHITMORE, WF

HUFFMAN, JL

FLEISHER, M

MELAMED, M

FANUCCHI, MP

HOLLANDER, P

VAUGHAN, ED

机构：

[1] MEM SLOAN KETTERING CANC CTR,SOLID TUMOR SERV,1275 YORK AVE,NEW YORK,NY 10021

[2] MEM SLOAN KETTERING CANC CTR,DEPT MED,DEV CHEMOTHERAPY SERV,NEW YORK,NY 10021

[3] MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021

[4] MEM SLOAN KETTERING CANC CTR,DEPT CLIN CHEM,NEW YORK,NY 10021

[5] MEM SLOAN KETTERING CANC CTR,DEPT SURG,UROL SERV,NEW YORK,NY 10021

[6] NEW YORK HOSP,DEPT SURG,UROL SERV,NEW YORK,NY 10021

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1986年 / 18卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：265 / 269

页数：5

共 15 条

[1]

ABBASSIAN A, 1966, J UROL, V86, P461

[2]

AHMED T, 1986, INVEST NEW DRUG, V4, P171

[3] WEEKLY PULSE METHOTREXATE IN RHEUMATOID-ARTHRITIS - CLINICAL AND IMMUNOLOGICAL EFFECTS IN A RANDOMIZED, DOUBLE-BLIND-STUDY [J].

ANDERSEN, PA ;

WEST, SG ;

ODELL, JR ;

VIA, CS ;

CLAYPOOL, RG ;

KOTZIN, BL .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (04) :489-496

[4]

COICOSTAIANO L, 1985, J UROL, V133, P786

[5]

HALL RR, 1981, CANCER TREAT REP, V65, P175

[6]

HERR HW, 1983, CANCER, V51, P1323, DOI 10.1002/1097-0142(19830401)51:7<1323::AID-CNCR2820510724>3.0.CO

[7]

2-2

[8]

KLEIN FA, 1982, CANCER, V50, P389, DOI 10.1002/1097-0142(19820801)50:3<389::AID-CNCR2820500302>3.0.CO

[9]

2-I

[10]

Scher H I, 1985, Semin Urol, V3, P239

← 1 2 →